Bill or rule · record ed1e88c6-df04-4920-9285-81eace9eeadc
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research; Guidance for Industry; Availability
What this record says
Bill or rule is a federal measure: Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research; Guidance for Industry; Availability Latest recorded action: Notice Terracotta's analytical effect: clinical research guidance for cannabis and cannabis-derived compounds aids research for both.
Related: All bill records
- Chamber
- Federal-Register
- Public display title
- Cannabis And Cannabis-Derived Compounds: Quality Considerations For Clinical Research; Guidance For Industry; Availability
- Impact
- Both Benefit
- Effect rationale
- Clinical Research Guidance For Cannabis And Cannabis-Derived Compounds Aids Research For Both
- Last action
- Jan 24, 2023
- Official source
- Open source
- Relevance
- Relevant
- Relevance Reason
- The Title Or Analyst Note Contains A Direct Hemp/Cannabis Policy Reference.
- Source Type
- Official
- State
- US
- Status
- Notice
- Title
- Cannabis And Cannabis-Derived Compounds: Quality Considerations For Clinical Research; Guidance For Industry; Availability
- Imported URL
- Open source